News

Qualitest said that after a thorough evaluation of multiple quality management solutions, it has selected a phased implementation of TrackWise software for its ability to deliver a flexible,

Microplasmin, ThromboGenics’ lead drug candidate, is a truncated form of the natural human protein plasmin. ThromboGenics has recently concluded two Phase III trials of Microplasmin, assessing the patients

Most recently, Bacopoulos worked as president and CEO of Aton Pharma. Prior to Aton Pharma, Bacopoulos served as the president and head of R&D at OSI Pharmaceuticals, where

DX-88 has received approval from the US Food and Drug Administration (FDA) and is marketed as Kalbitor (ecallantide) for the treatment of acute attacks of HAE in patients

Fondaparinux 1.5 and 2.5mg is indicated for the treatment of adults with acute symptomatic spontaneous superficial-vein thrombosis of the lower limbs without concomitant deep-vein thrombosis. Fondaparinux has received

Duke joins Johns Hopkins Hospital which is already conducting the Phase I trial of NPC-1C. In addition to Johns Hopkins, North Shore – LIJ has also enrolled patients

The pre-filled syringes provide a simplified dosing option for the treatment of opioid-induced constipation (OIC) in palliative-care patients with advanced illness. Progenics said that the new pre-filled syringes

As per the terms of the agreement, Eisai is expected to grant Brain Factory the exclusive rights to develop, commercialise, and sublicense ravuconazole prodrug in Japan as an

The RevitaLens Ocutec multi-purpose disinfecting solution delivers high-quality disinfection and comfort for the user, with the convenience of a single bottle, Abbott said. Abbott Medical Optics senior vice